|
Status |
Public on Jul 19, 2021 |
Title |
A human liver cell-based system modeling a clinical prognostic liver signature combined with single-cell RNA-Seq for discovery of liver disease therapeutics |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Abstract: Chronic liver disease and hepatocellular carcinoma (HCC) are life-threatening with limited treatment options. The lack of clinically relevant/tractable experimental models hampers therapeutic discovery. We developed a simple and robust human liver cell-based system modeling a clinical prognostic liver signature (PLS) predicting long-term liver disease progression toward HCC. Using the PLS as a readout, followed by validation in NASH-HCC animal models and patient-derived tumorspheroids, we identified nizatidine, a histamine receptor H2 (HRH2) blocker, for treatment of advanced liver disease and HCC chemoprevention. Perturbation studies combined with scRNA-Seq analyses of patient liver tissues uncovered HRH2+, CLEC5Ahigh, MARCOlow liver macrophages and hepatocytes as nizatidine targets. The PLS model combined with scRNA-Seq of patient tissues enables discovery of urgently needed targets and therapeutics for treatment of advanced liver disease and cancer prevention.
|
|
|
Overall design |
We performed bulk RNA sequencing of DMSO differentiated Huh751 at different time points
|
|
|
Contributor(s) |
Crouchet E, Zhu S, Hoshida Y, Baumert TF |
Citation(s) |
34535664 |
Submission date |
Mar 17, 2021 |
Last update date |
Jun 29, 2022 |
Contact name |
Shijia Zhu |
E-mail(s) |
shijia.zhu@utsouthwestern.edu
|
Organization name |
University of Texas Southwestern Medical Center
|
Street address |
5323 Harry Hines Blvd
|
City |
DALLAS |
State/province |
Texas |
ZIP/Postal code |
75390 |
Country |
USA |
|
|
Platforms (1) |
|
Samples (12)
|
|
This SubSeries is part of SuperSeries: |
GSE66843 |
A cell-based model unravels drivers for hepatocarcinogenesis and targets for clinical chemoprevention |
|
Relations |
BioProject |
PRJNA715183 |
SRA |
SRP311067 |